PMID: 25797294Mar 24, 2015Paper

SNP genetic polymorphisms of MDR-1, CYP1A2 and CYPB11 genes in four canine breeds upon toxicological evaluation

Journal of Veterinary Science
Rosa GagliardiM Victoria Arruga

Abstract

The fields of pharmacogenetics and pharmacogenomics have become increasingly promising regarding the clinical application of genetic data to aid in prevention of adverse reactions. Specific screening tests can predict which animals express modified proteins or genetic sequences responsible for adverse effects associated with a drug. Among the genetic variations that have been investigated in dogs, the multidrug resistance gene (MDR) is the best studied. However, other genes such as CYP1A2 and CYP2B11 control the protein syntheses involved in the metabolism of many drugs. In the present study, the MDR-1, CYP1A2 and CYP2B11 genes were examined to identify SNP polymorphisms associated with these genes in the following four canine breeds: Uruguayan Cimarron, Border Collie, Labrador Retriever and German Shepherd. The results revealed that several SNPs of the CYP1A2 and CYP2B11 genes are potential targets for drug sensitivity investigations.

References

Apr 1, 1997·Toxicology and Applied Pharmacology·G R LankasD Umbenhauer
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Dec 14, 2001·AAPS PharmSci·L MancinelliW Sadée
Oct 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Richard A GrahamAndrew Parkinson
Aug 4, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mark W NeffNiels C Pedersen
Nov 27, 2004·Pharmacogenetics·Masashi MiseToshihiko Fujii
Mar 4, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D TenmizuH Kamimura
Dec 13, 2005·Nature·Kerstin Lindblad-TohEric S Lander
May 25, 2006·Bioinformatics·Xavier SoléVíctor Moreno
Nov 15, 2006·Journal of Clinical Pharmacology·Robert L WalskyR Scott Obach
Apr 1, 2007·Drug Metabolism Letters·Valerie J WhiterockMichael W Sinz
May 7, 2010·Journal of Veterinary Pharmacology and Therapeutics·M T BarattaC W Locuson
Jan 12, 2011·Journal of Veterinary Pharmacology and Therapeutics·J S Aretz, J Geyer
Apr 15, 2011·Journal of Veterinary Internal Medicine·L AlvesM Drögemüller
Jun 4, 2011·Genetics and Molecular Biology·Rosa GagliardiMaría Victoria Arruga
Nov 15, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Valerie J WhiterockMichael W Sinz
Sep 25, 2012·Journal of Veterinary Internal Medicine·K R MuñanaK L Mealey
May 15, 2013·Nucleic Acids Research·Hamish McWilliamRodrigo Lopez

❮ Previous
Next ❯

Citations

Sep 12, 2017·Journal of Veterinary Pharmacology and Therapeutics·K Kongara
Jun 20, 2018·Journal of Veterinary Pharmacology and Therapeutics·Marilyn N MartinezKatrina L Mealey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Kouichi Kurose, Yoshiro Saito
Nihon rinsho. Japanese journal of clinical medicine
Yoshiro SaitoJun-ichi Sawada
Yi chuan xue bao = Acta genetica Sinica
Yan-Hong LiLing Yang
© 2021 Meta ULC. All rights reserved